source
- STAT+: Eli Lilly tops prominent rankings on pharma R&D performanceA new set of lists ranks drug company laboratories on two criteria: innovation and invention.STAT · 2mo ago↗ source
- The latest on Ebola: A travel ban and an old vaccineAffordable Care Act changes, drinking while pregnant, and more health news from Morning RoundsSTAT · 2mo ago↗ source
- Relay's PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies studyRelay Therapeutics’ first data readout for zovegalisib in a rare genetic disease beat Wall Street expectations, expanding the PI3Kα inhibitor’s R&D prospects beyond breast cancer. The biotech on Tu…Endpoints · 2mo ago↗ source